Unbiased chemokine receptor screening reveals similar efficacy of lymph node- and tumor-targeted T cell immunotherapy.

Cancer Immunol Immunother · 2023 · PMC10412482 · PMID 37301772

Europe PMC DOI

hedged sentence

0.0505

closest p · 1.0× alpha

0.0505

boldest claim

The sentences

almost significantlyp = 0.0505so close (0.05 < p ≤ 0.1)

Combining data from all conducted experiments, CCR6-transduced T cells significantly and CCR4-transduced T cells almost significantly ( p = 0.0505) prolonged survival compared to control-transduced T cells (median survival of 47 and 44.5 vs. 33 days, respectively).

also in 555 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.